1. Home
  2. TEVA vs GPC Comparison

TEVA vs GPC Comparison

Compare TEVA & GPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • GPC
  • Stock Information
  • Founded
  • TEVA 1901
  • GPC 1928
  • Country
  • TEVA Israel
  • GPC United States
  • Employees
  • TEVA N/A
  • GPC N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • GPC Automotive Aftermarket
  • Sector
  • TEVA Health Care
  • GPC Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • GPC Nasdaq
  • Market Cap
  • TEVA 19.7B
  • GPC 19.3B
  • IPO Year
  • TEVA N/A
  • GPC N/A
  • Fundamental
  • Price
  • TEVA $18.38
  • GPC $113.08
  • Analyst Decision
  • TEVA Strong Buy
  • GPC Buy
  • Analyst Count
  • TEVA 8
  • GPC 7
  • Target Price
  • TEVA $19.25
  • GPC $159.00
  • AVG Volume (30 Days)
  • TEVA 4.9M
  • GPC 975.0K
  • Earning Date
  • TEVA 11-06-2024
  • GPC 10-22-2024
  • Dividend Yield
  • TEVA N/A
  • GPC 3.49%
  • EPS Growth
  • TEVA N/A
  • GPC N/A
  • EPS
  • TEVA N/A
  • GPC 7.76
  • Revenue
  • TEVA $16,290,000,000.00
  • GPC $23,302,280,000.00
  • Revenue This Year
  • TEVA $4.59
  • GPC $2.85
  • Revenue Next Year
  • TEVA $4.06
  • GPC $4.21
  • P/E Ratio
  • TEVA N/A
  • GPC $14.57
  • Revenue Growth
  • TEVA 8.48
  • GPC 1.19
  • 52 Week Low
  • TEVA $8.07
  • GPC $113.93
  • 52 Week High
  • TEVA $19.08
  • GPC $164.45
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 59.65
  • GPC 21.45
  • Support Level
  • TEVA $17.73
  • GPC $133.01
  • Resistance Level
  • TEVA $18.33
  • GPC $144.29
  • Average True Range (ATR)
  • TEVA 0.38
  • GPC 2.69
  • MACD
  • TEVA 0.10
  • GPC -1.09
  • Stochastic Oscillator
  • TEVA 93.00
  • GPC 1.06

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About GPC Genuine Parts Company

Genuine Parts sells aftermarket automotive parts (about 60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations of which about two thirds are independently owned and operated. we estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of sales derived from professional customers. Its industrial segment, primarily operating under the Motion banner in the United States, serves as a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer clients.

Share on Social Networks: